BIOMAT Database Logo BIOMAT Database Logo

Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. 2022

Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Center for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

Lysine L-lactylation [K(L-la)] is a newly discovered histone mark stimulated under conditions of high glycolysis, such as the Warburg effect. K(L-la) is associated with functions that are different from the widely studied histone acetylation. While K(L-la) can be introduced by the acetyltransferase p300, histone delactylases enzymes remained unknown. Here, we report the systematic evaluation of zinc- and nicotinamide adenine dinucleotide–dependent histone deacetylases (HDACs) for their ability to cleave ε-N-L-lactyllysine marks. Our screens identified HDAC1–3 and SIRT1–3 as delactylases in vitro. HDAC1–3 show robust activity toward not only K(L-la) but also K(D-la) and diverse short-chain acyl modifications. We further confirmed the de-L-lactylase activity of HDACs 1 and 3 in cells. Together, these data suggest that histone lactylation is installed and removed by regulatory enzymes as opposed to spontaneous chemical reactivity. Our results therefore represent an important step toward full characterization of this pathway’s regulatory elements.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D006655 Histone Deacetylases Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes. Class I Histone Deacetylases,Class II Histone Deacetylases,HDAC Proteins,Histone Deacetylase,Histone Deacetylase Complexes,Complexes, Histone Deacetylase,Deacetylase Complexes, Histone,Deacetylase, Histone,Deacetylases, Histone
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations

Related Publications

Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study.
November 2010, Journal of clinical pathology,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.
December 2008, BMC cancer,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma.
June 2010, Expert opinion on therapeutic targets,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Class I lysine deacetylases facilitate glucocorticoid-induced transcription.
October 2013, The Journal of biological chemistry,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
New endogenous regulators of class I histone deacetylases.
January 2010, Science signaling,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Targeting class I histone deacetylases in cancer therapy.
January 2013, Expert opinion on therapeutic targets,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.
January 2012, PloS one,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
November 2014, Epigenetics,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Elevated immunoreactivity against class I histone deacetylases in adenomyosis.
January 2012, Gynecologic and obstetric investigation,
Carlos Moreno-Yruela, and Di Zhang, and Wei Wei, and Michael Bæk, and Wenchao Liu, and Jinjun Gao, and Daniela Danková, and Alexander L Nielsen, and Julie E Bolding, and Lu Yang, and Samuel T Jameson, and Jiemin Wong, and Christian A Olsen, and Yingming Zhao
Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
November 2022, Cells,
Copied contents to your clipboard!